INNATE PHARMA : IPH4102: Completion of the dose escalation part of the phase I trial - Data to be presented at ICML in June 2017 ...
IPH4102: Completion of THE dose escalation PART OF THE PHASE I TRIAL - DATA TO BE PRESENTED AT International Conference on Malignant Lymphoma IN JUNE 2017 IN LUGANO Complete safety results and updated clinical activity data will be presented at the ICML …